Form D · Pharmaceuticals

KYTHERA BIOPHARMACEUTICALS INC

Calabasas, CA · CIK 0001436304

Offering snapshot reported Sep 15, 2011 · SEC filing

Reported sold
$37.4M
Offering amount: $52.4M
Investors reported
20
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 30, 2011
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 15, 2011Initial$37,424,989No comparison20SEC filing
May 23, 2008PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity, Other
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$1.01M
Finders' fees
$4.74K
Form D file number
021-165882
Series D Preferred Stock; Common Stock issuable upon conversion thereof

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Leerink Swann LLC39011

Source: Form D, filed Sep 15, 2011. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Nathaniel David Director
Dennis Fenton Director
Hironori Hozoji Director
Keith Klein Executive
Francois Kress Director
Keith Leonard Director, Executive
Robert Nelsen Director
Camille Samuels Director
David Schnell Director
John Smither Executive
Joseph Turner Director
Patricia Walker Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
27200 West Agoura Road Suite 200
Calabasas, CA, 91301